4.47
price down icon1.54%   -0.07
after-market Handel nachbörslich: 4.47
loading

Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
1.00M%
10.01
-0.001 25.20 0.119 0.226
Operating Expenses
8.87%
100.37
92.19 98.78 106.17 101.40
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
8.87%
100.37
92.19 98.78 106.17 101.40
Operating Income/Loss
1.99%
-90.36
-92.20 -73.58 -106.05 -101.18
Income/Loss From Continuing Operations Before Tax
1.00M%
10.01
-0.001 25.20 -98.50 -94.24
Income/Loss From Continuing Operations After Tax
2.52%
-81.39
-83.50 -65.73 -98.50 -94.24
Net Income/Loss
2.52%
-81.39
-83.50 -65.73 -98.50 -94.24
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
17,740%
130.84
0.7334 122.23 121.68 121.32
Basic Earnings Per Share
7.46%
-0.62
-0.67 -0.54 -0.81 -0.78
Diluted Earnings Per Share
7.46%
-0.62
-0.67 -0.54 -0.81 -0.78
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$39.42
price down icon 3.95%
$351.17
price down icon 0.32%
$21.50
price down icon 3.85%
$5.30
price down icon 2.03%
biotechnology ONC
$224.99
price down icon 0.84%
$123.77
price up icon 2.39%
Kapitalisierung:     |  Volumen (24h):